Imiglucerase
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 317 publications
Diagnosis and follow-up of the first case of Gaucher disease under enzyme replacement therapy in Senegal.
Journal: Ghana medical journal
Published: June 05, 2026
Establishment of an N-Glycan Profiling Method for Three ERT Enzymes Used in Gaucher Disease Therapy.
Establishment of an N-Glycan Profiling Method for Three ERT Enzymes Used in Gaucher Disease Therapy.
Journal: Molecules (Basel, Switzerland)
Published: April 13, 2026
Quantitative and Comparative Assessment of Recombinant Human β-Glucocerebrosidase Uptake Bioactivity Using a Stable hMMR-Expressing CHO Cell Model.
Journal: Molecules (Basel, Switzerland)
Published: November 27, 2025
Maternal and Fetal Outcomes in Imiglucerase-Treated Patients With Gaucher Disease: Real-World Evidence From the International Collaborative Gaucher Group (ICGG) Gaucher Registry Pregnancy Sub-Registry.
Journal: Journal of inherited metabolic disease
Published: October 09, 2025
Ten-Year Follow-Up of Taliglucerase Alfa in Type 1 Gaucher Disease: Real-World Evidence from Albania.
Journal: Journal of clinical medicine
Published: September 02, 2025
The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.
Journal: Orphanet journal of rare diseases
Published: August 07, 2025
Diagnosis and genetic analysis of Gaucher disease in a pediatric case: a case report.
Journal: Frontiers in pediatrics
Published: May 14, 2025
Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?
Journal: PharmacoEconomics - open
Published: April 08, 2025
Investigating the therapeutic profile of velaglucerase alfa in paediatric patients with Gaucher disease: a systematic review across all paediatric age groups.
Journal: Orphanet journal of rare diseases
Published: February 26, 2025
Cost-effectiveness analysis of ambroxol for the treatment of Chinese patients with Gaucher disease.
Journal: Frontiers in medicine
Published: January 30, 2025
Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease
Journal: Terapevticheskii arkhiv
Published: January 23, 2025
Real-world experience of switching to taliglucerase among patients with Gaucher disease in Québec: A case series.
Journal: Molecular genetics and metabolism reports
Published: January 03, 2025
Last Updated: 06/30/2026